SKP2 and urogenital neoplasm: Additionally, KDM5B protein stability was regulated by S-phase kinase associated protein-2 (SKP2), which elevated H3K4me3 level to facilitate prostate carcinogenesis by promoting ubiquitination-dependent degradation of KDM5B [31].